Objective: Cortical spreading depolarizations (CSDs) are intense and ubiquitous depolarization waves relevant for the pathophysiology of migraine and brain injury. CSDs disrupt the blood-brain barrier (BBB), but the mechanisms are unknown. Methods: A total of six CSDs were evoked over 1 hour by topical application of 300 mM of KCl or optogenetically with 470 nm (blue) LED over the right hemisphere in anesthetized mice (C57BL/6 J wild type, Thy1-ChR2-YFP line 18, and cav-1 -/-). BBB disruption was assessed by Evans blue (2% EB, 3 ml/kg, intra-arterial) or dextran (200 mg/kg, fluorescein, 70,000 MW, intra-arterial) extravasation in parietotemporal cortex at 3 to 24 hours after CSD. Endothelial cell ultrastructure was examined using transmission electron microscopy 0 to 24 hours after the same CSD protocol in order to assess vesicular trafficking, endothelial tight junctions, and pericyte integrity. Mice were treated with vehicle, isoform nonselective rho-associated kinase (ROCK) inhibitor fasudil (10 mg/kg, intraperitoneally 30 minutes before CSD), or ROCK-2 selective inhibitor KD025 (200 mg/kg, per oral twice-daily for 5 doses before CSD). Results: We show that CSD-induced BBB opening to water and large molecules is mediated by increased endothelial transcytosis starting between 3 and 6 hours and lasting approximately 24 hours. Endothelial tight junctions, pericytes, and basement membrane remain preserved after CSDs. Moreover, we show that CSD-induced BBB disruption is exclusively caveolin-1-dependent and requires rho-kinase 2 activity. Importantly, hyperoxia failed to prevent CSD-induced BBB breakdown, suggesting that the latter is independent of tissue hypoxia. Interpretation: Our data elucidate the mechanisms by which CSDs lead to transient BBB disruption, with diagnostic and therapeutic implications for migraine and brain injury.
C ortical spreading depolarizations (CSDs) are intense neuroglial pandepolarization waves that slowly propagate (millimeters per minute) within contiguous gray matter. (Leao, 1944) Evolutionarily highly conserved from insect to man, CSDs are the electrophysiological substrate of migraine aura, (Ayata, 2010) and numerous recurrent CSD waves occur spontaneously for hours and days after brain injury, worsening the outcome. (Lauritzen et al., 2011 ;
CSD Induction and Monitoring
Mice were anesthetized with isoflurane (2.5% induction, 1% maintenance in 70% N 2 O/30% O 2 ), and rectal temperature was kept at 37 AE0.5 C throughout the anesthesia. Femoral artery was catheterized for continuous measurement of blood pressure (PowerLab; ADInstruments, Colorado Springs, MO) and injection of Evans blue or 70KDa fluorescein isothiocyanate (FITC)-dextran. Two burr holes were drilled (1.5 mm anterior, 1.5 mm posterior, 2 mm lateral to the bregma) for CSD monitoring by extracellular steady (DC) potential and electrocorticogram recordings using a differential amplifier (EX1; Dagan Corporation, Minneapolis, MN), glass capillary microelectrodes (tip diameter~10 μm, filled with 1 M of NaCl) placed 200 μm deep into the cortex, and an analog to digital converter (PowerLab; ADInstruments). A third burr hole over the occipital cortex (<500 μm dural exposure) was used to briefly (<1 minute) apply a cotton ball soaked in 300 mM of KCl. The cortex was immediately washed with normal saline as soon as a CSD was detected. In our experience, small area and brief time of exposure, as well as high K + clearance capacity of brain tissue, limit K + transfer by convection in paravascular spaces, so that extracellular K + concentrations always remain stable when measured by K + -selective electrodes >1 mm away from the KCl application site (data not shown). Amplitude and duration at half-amplitude of the first CSD in each hemisphere were measured. In a separate cohort, we induced CSDs noninvasively through intact skull using transgenic mice expressing channelrhodopsin-2 (Thy1-ChR2-YFP) in neurons as previously described. (Chung et al., 2018; Houben et al., 2017) Briefly, the skull was exposed by midline scalp incision and cleared of connective tissue. Care was taken to prevent bone drying with application of mineral oil in order to maintain skull translucency. A 400-μm diameter optical fiber was positioned over the motor cortex (2 mm anterior and 2 mm lateral to bregma). CSDs were induced optogenetically with 470 nm of (blue) LED (MF470F3, DC2100; Thorlabs, Newton, NJ) delivered for 10 seconds at 3 mW total power. A microscope objective USB camera (MU300, AmScope, Irvine, CA) coupled to a dissecting stereomicroscope illuminated with unfiltered white light was used to take time-lapse intrinsic signal images every 2 seconds. The intrinsic signal is a wellestablished method to detect blood volume changes caused by CSDs. (Chung et al., 2018; Yuzawa et al., 2012) CSDs were detected in real time by subtraction of adjacent images using MATLAB (The MathWorks, Inc., Natick, MA). Every stimulus under these conditions resulted in a CSD. After CSD inductions, local anesthetic (lidocaine gel 2%) was applied and mice were allowed to recover from anesthesia until the time of sacrifice using 5% isoflurane inhalation.
Brain Water Content
Six or 48 hours after CSD, parietotemporal cortex from CSD and non-CSD (nCSD) sides were removed, weighed, and dried at 99 C for 48 hours and reweighed. Water content (%) was calculated as [(wet weight -dry weight)/wet weight] × 100.
Evans Blue Leakage
Evans blue (2%) was injected (3 ml/kg, 60 mg/kg) by the femoral artery right after the last CSD. At this dose level, the vast majority (>98%) of EB is bound to plasma proteins, predominantly albumin. (Saunders et al., 2015) Mice were transcardially perfused with cold 0.9% NaCl, and the parietotemporal cortex from CSD and nCSD hemispheres were dissected, weighed, and homogenized in a 7-fold volume of 50% trichloroacetic acid with sonication for 2 minutes. After centrifugation (3,000 g for 20 minutes), supernatants were diluted 4-fold with ethanol. Fluorescence intensity was measured by a microplate fluorescence reader (620 nm excitation, 680 nm emission; Wallac; PerkinElmer, Wellesley, MA). Calculations were based on external standard readings, and extravasated dye was expressed as ng/mg tissue.
Dextran Extravasation
Dextran (200 mg/kg, fluorescein, 70,000 MW, Anionic, Lysine Fixable; Thermo Fisher Scientific, Waltham, MA) was injected through femoral artery 6 or 48 hours after the last CSD. After 1 hour of dextran circulation, brains were removed and freshly frozen in 2-methylbutane on dry ice. Cryosections (12μm) were obtained and mounted on gelatinized slides. After air drying for 15 minutes, sections were postfixed in 4% paraformaldehyde (PFA) at room temperature for 15 minutes, washed in phosphate-buffered saline (PBS), and co-stained with isolectin B4 to visualize blood vessels (1:500; I21411; Molecular Probes, Eugene, OR). Sections were cover-slipped with mounting medium containing 4',6-diamidino-2-phenylindole (DAPI; Vector Laboratories, Burlingame, CA), dried overnight, and analyzed with a laser scanning confocal microscope. Quantification of vessel leakage was performed as previously described. In brief, confocal images of 12-μm-thick brain sections from tracer-injected animals were co-stained with lectin and analyzed using ImageJ (NIH, Bethesda, MD). The same acquisition parameters were applied to all images and the same threshold was used. Tracer-positive area outside a vessel (parenchyma) was used as a parameter for leakage. For each hemisphere, at least 10 sections of a fixed lateral cortical plate area were scored. Average representation of each leakage group was calculated for ipsi-and contralateral hemispheres.
Transmission Electron Microscopy
Tissue processing for transmission electron microscopy (TEM) was performed as described previously. For analysis of endothelial ultrastructure (ie, tight junctions [TJs] and vesicles) mice were perfused through the heart with PBS followed by fixative solutions. The brain was removed, postfixed, and washed. Coronal 50-μm-thick brain sections were processed free floating. Ultrathin sections were then cut, collected on grids, counterstained, and examined under a 1200EX electron microscope (JEOL USA Inc., Peabody, MA) equipped with a 2 k CCD digital camera (Advanced Microscopy Techniques Corp., Woburn, MA). All ultrastructural quantifications were performed using ImageJ (NIH). Measures of TJ structure (length, width, thickness, and angle) as well as basement membrane thickness were performed on 10 images (40,000× magnification) per hemisphere (nCSD versus CSD; n = 3 mice) at each time point post-CSD (0, 3, 6, 12, 24, and 48 hours) . Basement membrane thickness (nm) was measured manually using ImageJ (NIH); three measures were obtained per capillary profile and averaged. To quantify endothelial vesicle counts, each capillary profile was imaged by two electron micrographs (12,000× magnification), each covering half the capillary profile. Endothelial vesicles were manually counted in 10 capillary cross-sectional profiles per hemisphere (nCSD versus CSD; n = 3 mice) at each time point post-CSD (0, 3, 6, 12, 24 , and 48 hours; ie, 20 micrographs/ hemisphere/time point). Vesicle counts from 10 capillaries were averaged within each animal to obtain a single data point per animal. Coefficient of variation of vesicle counts within each animal was 54 AE2% (mean AEstandard error of the mean [SEM]) when averaged across a representative cohort. Data were expressed as number per endothelial cytoplasmic area (μm 2 ) for "free" cytoplasmic vesicles, or per plasma membrane length (μm) for membrane-connected vesicles.
For analysis of transcytosis/leakage, horseradish peroxidase (HRP) type II (10 mg/20 g in PBS; Sigma-Aldrich, St. Louis, MO) was injected through a femoral artery catheter 6 and 24 hours after CSD induction. After 30 minutes of HRP circulation, brains were dissected and fixed in a sodium-cacodylatebuffered mixture followed by PFA and washes. Tissue sections (50μm) were then processed free floating. To reveal HRP as an electron dense precipitate, sections were incubated in a TrisHCl buffer containing 3-3' diaminobenzidine and H 2 O 2 , postfixed in osmium tetroxide, and dehydrated and embedded in epoxy resin. Imaging and quantification of HRP-filled vesicles followed the same protocol as above.
Histology
Immunohistochemistry was performed as previously described. Lacoste et al., 2014) Pericyte coverage of cortical vessels was quantified by analyzing the proportion of total CD31-positive endothelial length also positive for pericyte marker neural/glial antigen 2 (NG2). Pericyte coverage of brain microvascular networks was quantified on low-magnification confocal images as the ratio between the total area of NG2-positive capillaries and the total area of CD31-positive capillaries.
Pharmacological Studies
Mice were randomized to receive vehicle (saline, 0.1 ml), or isoform-nonselective ROCK inhibitor fasudil (10 mg/kg; Tocris Bioscience, Bristol, UK) by intraperitoneal injection 1 hour before CSD induction. The ROCK2-selective inhibitor, KD025 (formerly SLx-2119; 200 mg/kg; Kadmon Corp. LLC, New York, NY), or its vehicle (0.4% methylcellulose) was administered every 12 hours by orogastric gavage for 48 hours before to 24 hours after CSD induction. These doses were chosen based on previous reports in mice from our laboratory. (Lee et al., 2014; Shin et al., 2007) 
RT-qPCR
Total RNA was isolated from CSD and non-CSD brain tissue using the illustra RNAspin Mini Kit (GE Healthcare Life Sciences, Pittsburg, PA), and reverse transcription was performed using the SuperScript III first-strand synthesis system (Invitrogen, Carlsbad, CA), according to the manufacturer's recommendations. The following primers were used: ROCK1 5'-CTGCTGAAGTCGTGCTTGCA-3' (forward primer) and 5'-AGCATGTTATCGGGCTTCACA-3' (reverse primer); ROCK2, 5'-CTGAA-TGAAATGCAGGCTCAA-3' (forward primer); and 5'-CCCTGGTCCACTGCCTATAC-3' (reverse primer). PCR products were quantified by the ABI Prism 7500 Sequence Detection System.
Study Design and Statistical Analysis
Non-CSD hemispheres served as the control for CSD hemispheres within each animal. All experiments testing an intervention (ROCK inhibition, cav-1 -/-knockout) were carried out and analyzed in a blinded fashion. Analyses were made by Prism software (version 6; GraphPad Software, Inc., La Jolla, CA). Data are presented as mean AESEM or as whisker-box plots. Whenever appropriate, differences between groups were determined by t test (two-group comparisons), or one-or two-way analysis of variance (ANOVA; multigroup comparisons) followed by posthoc analysis. In the absence of pilot data, initial sample sizes were selected empirically and the data from these were used to calculate final sample sizes to achieve 80% power to detect 50% effect size (α = 0.05). Sample sizes in electron microscopy (EM) cohorts (n = 3 mice, 20 replicates per mouse) are typical for this method. A p value <0.05 was considered statistically significant.
Results
Initial experiments aimed to characterize BBB opening after CSD and its time course. Brief topical (epidural) KCl application (300 mM for <1 minute followed by saline wash), the most frequently used depolarizing stimulus, (Ayata, 2013; Karatas et al., 2013) , reliably triggered a CSD in the occipital cortex, which propagated across the ipsilateral hemisphere as detected electrophysiologically by two serially placed glass microelectrodes ( Fig 1A) . Using this approach in mice, we triggered six CSDs over 1 hour.
(Eikermann-Haerter et al., 2012) Then, using three independent but complementary methods, we examined BBB integrity in the parietotemporal cortex, away from the KCl application site. The contralateral hemisphere served as an internal control, because CSD does not propagate between hemispheres under these experimental conditions. (Ayata, 2013) First, we measured parenchymal water content and found a marked increase at 6 hours post-CSD, and to a lesser extent at 24 hours, when compared with the contralateral hemisphere ( Fig 1B) . We next examined cerebral extravasation of Evans blue (EB) dye administered intravascularly immediately after the last CSD. At the selected dose, the vast majority of EB binds to serum albumin (~65 kDa), and the complex (~70 kDa) does not cross an intact BBB. (Saunders et al., 2015) As with cortical water content, EB extravasation significantly increased within 6 hours after CSDs compared with the contralateral hemisphere and progressed for at least 24 hours (Fig 1C, left) . In a separate group of mice, we found that even a single CSD was able to open the BBB, although its magnitude was smaller compared to six CSDs (Fig 1C,  middle) . Sham-operated mice showed very little EB leakage, and we found no histological evidence of cortical injury attributed to our CSD induction paradigm (data not shown). Nevertheless, because epidural KCl application is somewhat invasive (ie, requires craniotomy), we also triggered CSDs noninvasively through intact skull using optogenetics in channelrhodopsin-2 transgenic mice (Thy1-ChR2-YFP homozygous, line 18) and reproduced the EB leakage in the ipsilateral, but not the contralateral, hemisphere (Fig 1C, right) . The small, yet consistent, increase in parenchymal EB in the contralateral hemisphere in all these experiments likely reflects diffusion of EB from the ipsilateral hemisphere over time and, possibly, contamination with ipsilateral EB during tissue preparation. Last, because EB has significant shortcomings to assess BBB leakage, (Saunders et al., 2015) we confirmed these results by measuring the extravasation of 70 kDa FITC-dextran administered intravascularly 1 hour before sacrifice. We found significant 70 kDa FITC-dextran leakage at 6 hours post-CSD and complete closure of the BBB within 48 hours (Fig 1D) . Altogether, these complementary methods converge to a transient opening of the BBB that starts within 6 hours after CSD and resolves within 48 hours. We next examined the subcellular mechanisms underlying BBB leakage after CSD. Unlike peripheral endothelial cells, brain endothelial cells are characterized by highly specialized TJs preventing water-soluble molecules from passing between adjacent cells, as well as by low rates of transcytosis from the vessel lumen to the brain parenchyma. (Andreone et al., 2015; Chow and Gu, 2015) Therefore, after showing CSD-induced BBB permeability to large molecules, we examined the ultrastructural indices of BBB integrity following CSD in the same region of the cerebral cortex (ie, remote from the KCl application site). TEM showed TJs as electron-dense linear structures where adjacent membranes are tightly opposed (Fig 2A) . We did not find any change in TJ integrity, given that both the space between endothelial cells and endothelial thickness at the TJ remained constant throughout our temporal analysis following CSDs (Fig 2A) . Tight junctional length and angle did not appear significantly altered by CSD either (Fig 2B) . We further examined functional integrity of TJs following intravascular HRP injection. (Andreone et al., 2017; Ben-Zvi et al., 2014; Reese and Karnovsky, 1967) Once exposed to diaminobenzidine (DAB) and H 2 O 2 , an electron-dense reaction product precipitates and fills the vessel lumen. We found that TJ barrier function was preserved at all time points as HRP penetrated the intercellular spaces between neighboring endothelial cells only for short distances and stopped abruptly at TJ (aka, kissing points; Fig 2C) .
Whereas TJs remained unaffected by CSD, we found a remarkable increase in endothelial transcytosis (Fig 3) . Within 6 hours after CSD, density of endothelial vesicles increased by more than 50% compared with the contralateral hemisphere, peaked around 6 to 12 hours post-CSD, and gradually normalized over the next 24 hours (Fig 3A) . This increase was evident in both cytoplasmic and plasma membrane-connected vesicles (Fig 3B; see also luminal and abluminal plasma membrane- *** connected vesicles). Importantly, neither endothelial crosssectional area nor capillary diameter was altered at any time point after CSD, as relevant denominators for vesicle density (Fig 3C) . Presence of vesicles filled with HRP, HRP exocytosis on the abluminal side, and accumulation within the basement membrane all confirmed the directional transport from vessel lumen to brain parenchyma by transcytosis (Fig 4) .
The smaller size (~50 nm) and lack of electron-dense coating of the vesicles were consistent with caveolae rather than clathrin-coated vesicles. To distinguish between clathrin-and caveolin-dependent mechanisms of CSDinduced transcytosis, we assessed 70 kDa FITC-dextran extravasation in cav-1 -/-mice subjected to CSDs, and found that CSD-induced vascular leakage was completely absent in cav-1 -/-mice compared to age-matched WT controls of the same genetic background (Fig 5) . Because pericytes regulate the BBB, in part, by downregulating transcytosis, (Armulik et al., 2010; Bell et al., 2010; Villasenor et al., 2017) we also examined pericyte coverage and integrity, as well as their relationship to CSD-induced leakage. We found no change in microvascular coverage by pericytes 6 hours after CSD, at a time when transcytosis was already markedly increased ( Fig 6A) . Indeed, 70 kDa FITC-dextran often extravasated around capillary surfaces covered by pericytes (Fig 6B) . Ultrastructurally, pericytes appeared intact with normal attachment to the vessel wall and no sign of cellular distress (Fig 6C,D) . Basement membrane thickness also remained unaffected by CSDs (Fig 6D) . Together, these data establish that CSD-induced BBB disruption is caveolae dependent and does not involve TJ breakdown. To further understand the molecular mechanisms regulating caveolae-mediated transcytosis and BBB leakage after CSD, we next examined ROCK as a critical regulator of actin cytoskeleton and endothelial permeability. Pretreatment with isoform-nonselective ROCK inhibitor fasudil (10 mg/kg) abolished the increase in pinocytotic vesicle density after CSD compared to vehicle-treated animals (Fig 7A) , and prevented HRP transcytosis (Fig 7B) , without altering the endothelial area or capillary diameter ( Fig 7C) . As a result, CSD-induced increase in water content, EB leakage, and 70 kDa FITC-dextran extravasation were all significantly reduced or abolished by fasudil pretreatment (Fig 8) . Importantly, electrophysiological properties of CSDs (ie, amplitude and duration) were normal in both cav-1 -/-mice and mice treated with ROCK inhibitors (Table 1) . Suppression of BBB opening by fasudil might reflect a permissive role for ROCK in CSD-induced vascular permeability. To address this question, we performed realtime qPCR and found increased mRNA expression of both ROCK1 and ROCK2 isoforms in ipsilateral (CSD) cortical homogenates compared to the contralateral (non-CSD) hemisphere 6 hours after CSD (Fig 9A) , strongly suggesting that ROCK is upregulated by CSD, rather than being just a permissive factor, as a critical step in BBB opening. To determine the ROCK isoform responsible for BBB opening, we next tested the ROCK2-selective inhibitor, KD025 (200 mg/kg twice-daily for 48 hours before CSD), (Lee et al., 2014) and found it to be as effective as fasudil in preventing BBB leakage (Fig 9B) . This is consistent with data suggesting that ROCK2 is the predominant endothelial isoform regulating barrier function. (Beckers et al., 2015; De Silva et al., 2016) Last, but not the least, CSDs are known to cause a transient oxygen supply-demand mismatch raising the possibility that tissue hypoxia may be the trigger for BBB opening. (Piilgaard and Lauritzen, 2009; Takano et al., 2007; Yuzawa et al., 2012) To test this, we performed additional experiments by using normobaric hyperoxia (100% oxygen inhalation) during the period of CSD induction (1 hour), which is known to abrogate the relative tissue hypoxia observed during CSD. (Takano et al., 2007) Hyperoxic animals showed nearly identical increase in EB leakage 24 hours after CSDs (192 AE 9% of contralateral; n = 6) compared to the normoxic group (196 AE 9% of contralateral), arguing against hypoxia as a relevant trigger for BBB opening during CSD.
Discussion
Our data demonstrate that CSD disrupts the BBB exclusively by endothelial transcytosis, without affecting endothelial TJs, basement membrane, or pericytes. We also show that CSD-induced transcytosis is caveolin-1 dependent, and that both transcytosis and leakage after CSD require ROCK2 activity as a gatekeeper, likely through phosphorylation of caveolin-1. (Li et al., 2014) Altogether, our data establish the endothelial mechanism of BBB disruption by CSD.
The identity of the factor(s) linking the parenchymal (ie, neuroglial) depolarization during CSD to the endothelium to stimulate transcytosis is unknown. CSD is associated with major shifts in extracellular ion concentrations (eg, decreased pH, increased extracellular K + ) and massive increases in numerous neurotransmitters (eg, glutamate) that can overwhelm the usual reuptake and clearance mechanisms. (Ayata and Lauritzen, 2015) As a result, elevated extracellular levels of ions and neurotransmitters are likely to traverse the perivascular diffusional barriers (eg, astrocyte end feet) and reach the microvascular endothelial cells. Astrocytic end feet may, in fact, facilitate perivascular K + rise by siphoning. (Leis et al., 2005; Newman, 1986) Moreover, the secondary depolarization of perivascular nerves during CSD might release their vasoactive transmitters (eg, substance P). (Ayata and Lauritzen, 2015) Previous studies suggest that some of the CSD-induced ultrastructural changes can be pharmacologically modulated (eg, paracetamol, serotonergic transmission). (Maneesri et al., 2004; Saengjaroentham et al., FIGURE 5 : Caveolin-1 is required for CSD-induced BBB disruption. (a) Left panel shows low-magnification images of cortical 70 kDa FITC-dextran (green) leakage around blood vessels (red) in WT (upper panels) and absence of it in Cav-1 -/-(lower panels) mice 6 hours after KCl-induced CSDs. Right, quantification of 70 kDa FITC-dextran extravasation in the cerebral cortex. Whiskerbox plots show full (whiskers) and interquartile (box) ranges, as well as the median (horizontal line) and mean (+); *** p < 0.001 by one-way ANOVA followed by Turkey's post-hoc test. (b) Higher-magnification images to better illustrate the absence of leakage in Cav-1 -/-mice (lower panels) compared to WT mice (upper panels) 6 hours after KCl-induced CSDs. ANOVA = analysis of variance; BBB = blood-brain barrier; CSD = cortical spreading depolarization; DAPI = 4',6-diamidino-2-phenylindole; FITC = fluorescein isothiocyanate; IB4 = isolectin-B4; nCSD = non-CSD hemisphere; WT = wild type.
2015; Yisarakun et al., 2014) Given the multitude of potential signaling molecules simultaneously released during CSD in vivo, identifying the signal that triggers the endothelial phenotype change may require in vitro models.
An alternative explanation might be CSD-induced tissue hypoxia. However, CSD causes only a brief (<30 seconds) oxygen supply-demand mismatch within otherwise normal brain parenchyma, and normobaric hyperoxia, which effectively prevents the oxygen supply-demand mismatch during CSD, (Takano et al., 2007) did not block the BBB opening in our study, arguing against this possibility. In addition, noninvasive optogenetic induction of CSD also effectively disrupted the BBB, suggesting that tissue injury is not required.
Our findings have implications for migraine. CSD is the electrophysiological event underlying aura. (Ayata, 2010) Clinically, severe migraine auras, where multiple, long-lasting, or reverberating CSDs may occur (eg, hemiplegic migraine), (Eikermann-Haerter et al., 2009; Eikermann-Haerter et al., 2011; Ferrari et al., 2015) have been reported to show neuroimaging signs of BBB opening. (Cha et al., 2007; Dreier et al., 2005; Kors et al., 2001 ) Increased endothelial pinocytosis during classical migraine attacks has been suggested more than 40 years ago, in part based on cerebrospinal fluid/plasma protein ratios. (Harper et al., 1977; Kangasniemi et al., 1974) However, clinical studies have thus far failed to detect BBB opening after migraine attacks, likely because of technical limitations and study design. Hougaard et al., 2017; Schankin et al., 2016 ) Because a single CSD was also capable of triggering BBB leakage in our study, newer magnetic resonance imaging techniques to image "free water," such as diffusion-based models (ie, neurite orientation dispersion and density imaging) or T2 mapping, may be sensitive enough to detect BBB opening as a footprint even in classical migraine with aura, especially when properly timed. Given that BBB opening was delayed by several hours after CSD, plasma protein and water leakage are unlikely to be relevant for the headache phase. However, chronic episodic leakage of plasma constituents during frequent migraine aura attacks may be a potential mechanism for progressive neurovascular conditions linked to migraine with aura (eg, periventricular white matter disease). (Mawet et al., 2015) Last, opening of the BBB after CSD (ie, aura) might provide an entry route for novel migraine therapeutics that do not normally cross the BBB, such as antibodies targeting the calcitonin gene-related peptide system. (Tso and Goadsby, 2017 ).
An abundance of experimental and clinical data indicate that CSD plays a critical role in the pathophysiology of ischemic, hemorrhagic, and traumatic brain injury as well. (Lauritzen et al., 2011) Recurrent CSDs in injured brain promote secondary tissue loss and neurological deficits, making CSD a clinically relevant therapeutic target. Our data suggest that CSD alone (ie, without attendant tissue injury) recapitulates the morphological features and mechanisms of BBB opening after injury. (Cipolla et al., 2004; Dietrich et al., 1987; Haley and Lawrence, 2017; Ito et al., 1980; Knowland et al., 2014; Krueger et al., 2013; Lossinsky and Shivers, 2004; Nahirney et al., 2016) The overlap is substantial. For example, both caveolin-1 expression and phosphorylation are increased after an ischemic insult, and caveolin-1 knockout mice do not develop increased transcytosis or early BBB leakage after ischemia. (Knowland et al., 2014; Nag et al., 2007) Cerebral ischemia upregulates the RhoA/ROCK pathway as well (Brabeck et al., 2003; Erdo et al., 2004; Trapp et al., 2001) and RhoA/ROCK inhibitors attenuate edema in experimental models of brain injury. (Fu et al., 2014 ; Fujii et al., 2012; Gibson et al., 2014; Huang et al., 2012; Niego et al., 2017) Also consistent with our findings after CSD, cerebral ischemia did not alter basement membrane thickness, pericyte coverage, capillary diameter, or endothelial cell area. (Haley and Lawrence, 2017) Indeed, opening of the paracellular pathway occurs only during late stages of severe ischemic injury and is not triggered by CSD alone. As such, CSD is an example where trans-and paracellular BBB opening dissociates. (Kang et al., 2013) Importantly, in our experiments, where only a small number of CSDs were induced over 1 hour, BBB opening was transient, with spontaneous recovery within 48 hours. In the injured brain, recurrent CSDs continue to develop for many hours and even days after the initial insult, (Hartings et al., 2003; Kudo et al., 2016) which might explain the longer-lasting BBB opening after brain injury. Given that CSDs originating in injured brain often propagate into the normal tissue, they may explain the BBB opening in surrounding noninjured brain as well. (Lapilover et al., 2012; Stoll et al., 2009 ) Altogether, these data implicate CSDs in brain injury as a contributor to early BBB opening to large molecules and vasogenic edema that often becomes a clinically significant mechanism of secondary injury and sometimes herniation. (Ayata and Ropper, 2002 ) Therefore, therapeutic targeting of CSDs may diminish edema in injured brain. Last, we propose that the increase in endothelial transcytosis is only one sign of a dramatic endothelial change after CSD (ie, the tip of the iceberg). The transformation emerges after a delay of a few hours, presumably regulated at the transcriptional, translational, and/or posttranslational levels. Therefore, CSD may not be as innocuous as it is often believed to be, and the cerebrovascular endothelial phenotype shift may have implications for the increased cerebrovascular event risk in migraineurs with aura. 
